In 35 cases of advanced Hodgkin's disease (stage IIIB to IVB), of whom 33 were no longer responsive to the alkylating agents, vinblastine produced clinically useful remissions in 22 patients or 64%. Complete objective responses were unusual but one third of these cases experienced partial remissions
Hodgkin's disease biology: recent advances
✍ Scribed by Andrea Jox; Jürgen Wolf; Volker Diehl
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 130 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
✦ Synopsis
The cellular origin of H-RS cells has been questioned for a long time. Recently, using single cell amplification of Ig genes evidence was obtained that H-RS cells clonally arise from B-cells. Sequence analysis of rearranged Ig genes demonstrated that H-RS cells develop within the germinal centre. H-RS cells in classical HD grow despite loss of function of their rearranged Ig genes. In contrast, the mutation pattern of rearranged Ig genes in L & H cells of lymphocyte-predominant HD frequently shows ongoing mutations indicating that these cell are still antigen selected. These molecular differences show that LP HD genetically differs from classical HD. H-RS cells escape from apoptosis within the germinal centre. However, the events leading to malignant transformation are still unknown. The association between EBV and HD has been repeatedly described, but the occurrence of EBV negative cases is hard to explain just by loss of EBV. The analysis of chromosomal aberrations in H-RS cells did not result in the description of a specific 'HD-gene'. Also the role of the T-lymphocytes surrounding the H-RS cells has remained an open question.
📜 SIMILAR VOLUMES
Bleomycin was used to treat 31 patients with a variety of advanced, previously treated malignancies, with particular emphasis o n Hodgkin's disease and epidermoid cancers. Bleomycin was administered either twice weekly, 15 mg per dose, or in 5-day courses, 105 mg total dose per course. Three of 10 p